This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07389/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07389/identifier/pubchem-compound/
n4http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB07389/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07389/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07389
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n4:DB07389 n13:DB07389
dcterms:title
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE
adms:identifier
n6:99443860 n9:AT6 n10:10221335 n12:DB07389
n7:IUPAC-Name
n8:271B3FA5-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B3FAB-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B3FAA-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B3FA7-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B3FA8-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B3FA9-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B3FA3-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B3FA4-363D-11E5-9242-09173F13E4C5 n8:271B3FA1-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B3FA2-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B3FB1-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B3FB2-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B3FAC-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B3FAD-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B3FAF-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B3FAE-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B3FB0-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B3FB7-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B3FB9-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B3FBA-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B3FB6-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B3FB5-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B3FB8-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B3FA6-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B3FB3-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B3FB4-363D-11E5-9242-09173F13E4C5